Global Measles and Rubella Vaccines Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Measles and Rubella Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Measles and Rubella Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Measles and Rubella Vaccines market in any manner.
Global Measles and Rubella Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
Market Segmentation (by Type)
Monovalent Vaccines
Multivalent Vaccines
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Measles and Rubella Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Measles and Rubella Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Measles and Rubella Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Measles and Rubella Vaccines market in any manner.
Global Measles and Rubella Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Serum Institute of India Ltd.
Merck & Co. Inc.
GlaxoSmithKline Inc.
Takeda Pharmaceutical Company
Market Segmentation (by Type)
Monovalent Vaccines
Multivalent Vaccines
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Measles and Rubella Vaccines Market
- Overview of the regional outlook of the Measles and Rubella Vaccines Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Measles and Rubella Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Measles and Rubella Vaccines
1.2 Key Market Segments
1.2.1 Measles and Rubella Vaccines Segment by Type
1.2.2 Measles and Rubella Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MEASLES AND RUBELLA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Measles and Rubella Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Measles and Rubella Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MEASLES AND RUBELLA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Measles and Rubella Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Measles and Rubella Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Measles and Rubella Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Measles and Rubella Vaccines Sales Sites, Area Served, Product Type
3.6 Measles and Rubella Vaccines Market Competitive Situation and Trends
3.6.1 Measles and Rubella Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Measles and Rubella Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MEASLES AND RUBELLA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Measles and Rubella Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MEASLES AND RUBELLA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MEASLES AND RUBELLA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Measles and Rubella Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Measles and Rubella Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Measles and Rubella Vaccines Price by Type (2019-2024)
7 MEASLES AND RUBELLA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Measles and Rubella Vaccines Market Sales by Application (2019-2024)
7.3 Global Measles and Rubella Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Measles and Rubella Vaccines Sales Growth Rate by Application (2019-2024)
8 MEASLES AND RUBELLA VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Measles and Rubella Vaccines Sales by Region
8.1.1 Global Measles and Rubella Vaccines Sales by Region
8.1.2 Global Measles and Rubella Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Measles and Rubella Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Measles and Rubella Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Measles and Rubella Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Measles and Rubella Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Measles and Rubella Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Serum Institute of India Ltd.
9.1.1 Serum Institute of India Ltd. Measles and Rubella Vaccines Basic Information
9.1.2 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Overview
9.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Market Performance
9.1.4 Serum Institute of India Ltd. Business Overview
9.1.5 Serum Institute of India Ltd. Measles and Rubella Vaccines SWOT Analysis
9.1.6 Serum Institute of India Ltd. Recent Developments
9.2 Merck and Co. Inc.
9.2.1 Merck and Co. Inc. Measles and Rubella Vaccines Basic Information
9.2.2 Merck and Co. Inc. Measles and Rubella Vaccines Product Overview
9.2.3 Merck and Co. Inc. Measles and Rubella Vaccines Product Market Performance
9.2.4 Merck and Co. Inc. Business Overview
9.2.5 Merck and Co. Inc. Measles and Rubella Vaccines SWOT Analysis
9.2.6 Merck and Co. Inc. Recent Developments
9.3 GlaxoSmithKline Inc.
9.3.1 GlaxoSmithKline Inc. Measles and Rubella Vaccines Basic Information
9.3.2 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Overview
9.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Market Performance
9.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines SWOT Analysis
9.3.5 GlaxoSmithKline Inc. Business Overview
9.3.6 GlaxoSmithKline Inc. Recent Developments
9.4 Takeda Pharmaceutical Company
9.4.1 Takeda Pharmaceutical Company Measles and Rubella Vaccines Basic Information
9.4.2 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Overview
9.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Market Performance
9.4.4 Takeda Pharmaceutical Company Business Overview
9.4.5 Takeda Pharmaceutical Company Recent Developments
10 MEASLES AND RUBELLA VACCINES MARKET FORECAST BY REGION
10.1 Global Measles and Rubella Vaccines Market Size Forecast
10.2 Global Measles and Rubella Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Measles and Rubella Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Measles and Rubella Vaccines Market Size Forecast by Region
10.2.4 South America Measles and Rubella Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Measles and Rubella Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Measles and Rubella Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Measles and Rubella Vaccines by Type (2025-2030)
11.1.2 Global Measles and Rubella Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Measles and Rubella Vaccines by Type (2025-2030)
11.2 Global Measles and Rubella Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Measles and Rubella Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Measles and Rubella Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Measles and Rubella Vaccines
1.2 Key Market Segments
1.2.1 Measles and Rubella Vaccines Segment by Type
1.2.2 Measles and Rubella Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MEASLES AND RUBELLA VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Measles and Rubella Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Measles and Rubella Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MEASLES AND RUBELLA VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Global Measles and Rubella Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Measles and Rubella Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Measles and Rubella Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Measles and Rubella Vaccines Sales Sites, Area Served, Product Type
3.6 Measles and Rubella Vaccines Market Competitive Situation and Trends
3.6.1 Measles and Rubella Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Measles and Rubella Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MEASLES AND RUBELLA VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Measles and Rubella Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MEASLES AND RUBELLA VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MEASLES AND RUBELLA VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Measles and Rubella Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Measles and Rubella Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Measles and Rubella Vaccines Price by Type (2019-2024)
7 MEASLES AND RUBELLA VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Measles and Rubella Vaccines Market Sales by Application (2019-2024)
7.3 Global Measles and Rubella Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Measles and Rubella Vaccines Sales Growth Rate by Application (2019-2024)
8 MEASLES AND RUBELLA VACCINES MARKET SEGMENTATION BY REGION
8.1 Global Measles and Rubella Vaccines Sales by Region
8.1.1 Global Measles and Rubella Vaccines Sales by Region
8.1.2 Global Measles and Rubella Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Measles and Rubella Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Measles and Rubella Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Measles and Rubella Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Measles and Rubella Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Measles and Rubella Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Serum Institute of India Ltd.
9.1.1 Serum Institute of India Ltd. Measles and Rubella Vaccines Basic Information
9.1.2 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Overview
9.1.3 Serum Institute of India Ltd. Measles and Rubella Vaccines Product Market Performance
9.1.4 Serum Institute of India Ltd. Business Overview
9.1.5 Serum Institute of India Ltd. Measles and Rubella Vaccines SWOT Analysis
9.1.6 Serum Institute of India Ltd. Recent Developments
9.2 Merck and Co. Inc.
9.2.1 Merck and Co. Inc. Measles and Rubella Vaccines Basic Information
9.2.2 Merck and Co. Inc. Measles and Rubella Vaccines Product Overview
9.2.3 Merck and Co. Inc. Measles and Rubella Vaccines Product Market Performance
9.2.4 Merck and Co. Inc. Business Overview
9.2.5 Merck and Co. Inc. Measles and Rubella Vaccines SWOT Analysis
9.2.6 Merck and Co. Inc. Recent Developments
9.3 GlaxoSmithKline Inc.
9.3.1 GlaxoSmithKline Inc. Measles and Rubella Vaccines Basic Information
9.3.2 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Overview
9.3.3 GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Market Performance
9.3.4 GlaxoSmithKline Inc. Measles and Rubella Vaccines SWOT Analysis
9.3.5 GlaxoSmithKline Inc. Business Overview
9.3.6 GlaxoSmithKline Inc. Recent Developments
9.4 Takeda Pharmaceutical Company
9.4.1 Takeda Pharmaceutical Company Measles and Rubella Vaccines Basic Information
9.4.2 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Overview
9.4.3 Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Market Performance
9.4.4 Takeda Pharmaceutical Company Business Overview
9.4.5 Takeda Pharmaceutical Company Recent Developments
10 MEASLES AND RUBELLA VACCINES MARKET FORECAST BY REGION
10.1 Global Measles and Rubella Vaccines Market Size Forecast
10.2 Global Measles and Rubella Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Measles and Rubella Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Measles and Rubella Vaccines Market Size Forecast by Region
10.2.4 South America Measles and Rubella Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Measles and Rubella Vaccines by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Measles and Rubella Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Measles and Rubella Vaccines by Type (2025-2030)
11.1.2 Global Measles and Rubella Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Measles and Rubella Vaccines by Type (2025-2030)
11.2 Global Measles and Rubella Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Measles and Rubella Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Measles and Rubella Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Measles and Rubella Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Measles and Rubella Vaccines Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Measles and Rubella Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Measles and Rubella Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella Vaccines as of 2022)
Table 10. Global Market Measles and Rubella Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Measles and Rubella Vaccines Sales Sites and Area Served
Table 12. Manufacturers Measles and Rubella Vaccines Product Type
Table 13. Global Measles and Rubella Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Measles and Rubella Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Measles and Rubella Vaccines Market Challenges
Table 22. Global Measles and Rubella Vaccines Sales by Type (K Units)
Table 23. Global Measles and Rubella Vaccines Market Size by Type (M USD)
Table 24. Global Measles and Rubella Vaccines Sales (K Units) by Type (2019-2024)
Table 25. Global Measles and Rubella Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Measles and Rubella Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Measles and Rubella Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Measles and Rubella Vaccines Price (USD/Unit) by Type (2019-2024)
Table 29. Global Measles and Rubella Vaccines Sales (K Units) by Application
Table 30. Global Measles and Rubella Vaccines Market Size by Application
Table 31. Global Measles and Rubella Vaccines Sales by Application (2019-2024) & (K Units)
Table 32. Global Measles and Rubella Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Measles and Rubella Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Measles and Rubella Vaccines Market Share by Application (2019-2024)
Table 35. Global Measles and Rubella Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Measles and Rubella Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Global Measles and Rubella Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Measles and Rubella Vaccines Sales by Country (2019-2024) & (K Units)
Table 39. Europe Measles and Rubella Vaccines Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Measles and Rubella Vaccines Sales by Region (2019-2024) & (K Units)
Table 41. South America Measles and Rubella Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Measles and Rubella Vaccines Sales by Region (2019-2024) & (K Units)
Table 43. Serum Institute of India Ltd. Measles and Rubella Vaccines Basic Information
Table 44. Serum Institute of India Ltd. Measles and Rubella Vaccines Product Overview
Table 45. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Serum Institute of India Ltd. Business Overview
Table 47. Serum Institute of India Ltd. Measles and Rubella Vaccines SWOT Analysis
Table 48. Serum Institute of India Ltd. Recent Developments
Table 49. Merck and Co. Inc. Measles and Rubella Vaccines Basic Information
Table 50. Merck and Co. Inc. Measles and Rubella Vaccines Product Overview
Table 51. Merck and Co. Inc. Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck and Co. Inc. Business Overview
Table 53. Merck and Co. Inc. Measles and Rubella Vaccines SWOT Analysis
Table 54. Merck and Co. Inc. Recent Developments
Table 55. GlaxoSmithKline Inc. Measles and Rubella Vaccines Basic Information
Table 56. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Overview
Table 57. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline Inc. Measles and Rubella Vaccines SWOT Analysis
Table 59. GlaxoSmithKline Inc. Business Overview
Table 60. GlaxoSmithKline Inc. Recent Developments
Table 61. Takeda Pharmaceutical Company Measles and Rubella Vaccines Basic Information
Table 62. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Overview
Table 63. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Pharmaceutical Company Business Overview
Table 65. Takeda Pharmaceutical Company Recent Developments
Table 66. Global Measles and Rubella Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Measles and Rubella Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Measles and Rubella Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. North America Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Measles and Rubella Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Measles and Rubella Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 73. Asia Pacific Measles and Rubella Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Measles and Rubella Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. South America Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Measles and Rubella Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Measles and Rubella Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Measles and Rubella Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Measles and Rubella Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 81. Global Measles and Rubella Vaccines Sales (K Units) Forecast by Application (2025-2030)
Table 82. Global Measles and Rubella Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Measles and Rubella Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Measles and Rubella Vaccines Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Measles and Rubella Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Measles and Rubella Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Measles and Rubella Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella Vaccines as of 2022)
Table 10. Global Market Measles and Rubella Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Measles and Rubella Vaccines Sales Sites and Area Served
Table 12. Manufacturers Measles and Rubella Vaccines Product Type
Table 13. Global Measles and Rubella Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Measles and Rubella Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Measles and Rubella Vaccines Market Challenges
Table 22. Global Measles and Rubella Vaccines Sales by Type (K Units)
Table 23. Global Measles and Rubella Vaccines Market Size by Type (M USD)
Table 24. Global Measles and Rubella Vaccines Sales (K Units) by Type (2019-2024)
Table 25. Global Measles and Rubella Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Measles and Rubella Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Measles and Rubella Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Measles and Rubella Vaccines Price (USD/Unit) by Type (2019-2024)
Table 29. Global Measles and Rubella Vaccines Sales (K Units) by Application
Table 30. Global Measles and Rubella Vaccines Market Size by Application
Table 31. Global Measles and Rubella Vaccines Sales by Application (2019-2024) & (K Units)
Table 32. Global Measles and Rubella Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Measles and Rubella Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Measles and Rubella Vaccines Market Share by Application (2019-2024)
Table 35. Global Measles and Rubella Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Measles and Rubella Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Global Measles and Rubella Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Measles and Rubella Vaccines Sales by Country (2019-2024) & (K Units)
Table 39. Europe Measles and Rubella Vaccines Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Measles and Rubella Vaccines Sales by Region (2019-2024) & (K Units)
Table 41. South America Measles and Rubella Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Measles and Rubella Vaccines Sales by Region (2019-2024) & (K Units)
Table 43. Serum Institute of India Ltd. Measles and Rubella Vaccines Basic Information
Table 44. Serum Institute of India Ltd. Measles and Rubella Vaccines Product Overview
Table 45. Serum Institute of India Ltd. Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Serum Institute of India Ltd. Business Overview
Table 47. Serum Institute of India Ltd. Measles and Rubella Vaccines SWOT Analysis
Table 48. Serum Institute of India Ltd. Recent Developments
Table 49. Merck and Co. Inc. Measles and Rubella Vaccines Basic Information
Table 50. Merck and Co. Inc. Measles and Rubella Vaccines Product Overview
Table 51. Merck and Co. Inc. Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Merck and Co. Inc. Business Overview
Table 53. Merck and Co. Inc. Measles and Rubella Vaccines SWOT Analysis
Table 54. Merck and Co. Inc. Recent Developments
Table 55. GlaxoSmithKline Inc. Measles and Rubella Vaccines Basic Information
Table 56. GlaxoSmithKline Inc. Measles and Rubella Vaccines Product Overview
Table 57. GlaxoSmithKline Inc. Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. GlaxoSmithKline Inc. Measles and Rubella Vaccines SWOT Analysis
Table 59. GlaxoSmithKline Inc. Business Overview
Table 60. GlaxoSmithKline Inc. Recent Developments
Table 61. Takeda Pharmaceutical Company Measles and Rubella Vaccines Basic Information
Table 62. Takeda Pharmaceutical Company Measles and Rubella Vaccines Product Overview
Table 63. Takeda Pharmaceutical Company Measles and Rubella Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Takeda Pharmaceutical Company Business Overview
Table 65. Takeda Pharmaceutical Company Recent Developments
Table 66. Global Measles and Rubella Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Measles and Rubella Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 68. North America Measles and Rubella Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. North America Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 70. Europe Measles and Rubella Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 72. Asia Pacific Measles and Rubella Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 73. Asia Pacific Measles and Rubella Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 74. South America Measles and Rubella Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. South America Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 76. Middle East and Africa Measles and Rubella Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 77. Middle East and Africa Measles and Rubella Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 78. Global Measles and Rubella Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Measles and Rubella Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 80. Global Measles and Rubella Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)
Table 81. Global Measles and Rubella Vaccines Sales (K Units) Forecast by Application (2025-2030)
Table 82. Global Measles and Rubella Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Measles and Rubella Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Measles and Rubella Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Measles and Rubella Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Measles and Rubella Vaccines Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Measles and Rubella Vaccines Market Size by Country (M USD)
Figure 11. Measles and Rubella Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Measles and Rubella Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Measles and Rubella Vaccines Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Measles and Rubella Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Measles and Rubella Vaccines Market Share by Type
Figure 18. Sales Market Share of Measles and Rubella Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Measles and Rubella Vaccines by Type in 2023
Figure 20. Market Size Share of Measles and Rubella Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Measles and Rubella Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Measles and Rubella Vaccines Market Share by Application
Figure 24. Global Measles and Rubella Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Measles and Rubella Vaccines Sales Market Share by Application in 2023
Figure 26. Global Measles and Rubella Vaccines Market Share by Application (2019-2024)
Figure 27. Global Measles and Rubella Vaccines Market Share by Application in 2023
Figure 28. Global Measles and Rubella Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Measles and Rubella Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Measles and Rubella Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Measles and Rubella Vaccines Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Measles and Rubella Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Measles and Rubella Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Measles and Rubella Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Measles and Rubella Vaccines Sales Market Share by Region in 2023
Figure 44. China Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Measles and Rubella Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Measles and Rubella Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Measles and Rubella Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Measles and Rubella Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Measles and Rubella Vaccines Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Measles and Rubella Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Measles and Rubella Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Measles and Rubella Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Measles and Rubella Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Measles and Rubella Vaccines Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Measles and Rubella Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Measles and Rubella Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Measles and Rubella Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Measles and Rubella Vaccines Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Measles and Rubella Vaccines Market Size by Country (M USD)
Figure 11. Measles and Rubella Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Measles and Rubella Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Measles and Rubella Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Measles and Rubella Vaccines Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Measles and Rubella Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Measles and Rubella Vaccines Market Share by Type
Figure 18. Sales Market Share of Measles and Rubella Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Measles and Rubella Vaccines by Type in 2023
Figure 20. Market Size Share of Measles and Rubella Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Measles and Rubella Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Measles and Rubella Vaccines Market Share by Application
Figure 24. Global Measles and Rubella Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Measles and Rubella Vaccines Sales Market Share by Application in 2023
Figure 26. Global Measles and Rubella Vaccines Market Share by Application (2019-2024)
Figure 27. Global Measles and Rubella Vaccines Market Share by Application in 2023
Figure 28. Global Measles and Rubella Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Measles and Rubella Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Measles and Rubella Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Measles and Rubella Vaccines Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Measles and Rubella Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Measles and Rubella Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Measles and Rubella Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Measles and Rubella Vaccines Sales Market Share by Region in 2023
Figure 44. China Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Measles and Rubella Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Measles and Rubella Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Measles and Rubella Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Measles and Rubella Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Measles and Rubella Vaccines Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Measles and Rubella Vaccines Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Measles and Rubella Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Measles and Rubella Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Measles and Rubella Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Measles and Rubella Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Measles and Rubella Vaccines Market Share Forecast by Application (2025-2030)
